Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 843 | 2,129 | 8,404 | 1,169 | 2 |
| Marketable Securities | N/A | N/A | 1 | 66,104 | 65,825 |
| Receivables | 7,898 | 12,358 | 15,569 | 38 | N/A |
| Inventories | 162 | 2,122 | 1,550 | N/A | N/A |
| Income taxes - deferred | 25 | N/A | N/A | N/A | N/A |
| Other current assets | 120 | 0 | 3,000 | 3,000 | 0 |
| TOTAL | $11,103 | $19,499 | $32,897 | $70,385 | $65,904 |
| Non-Current Assets | |||||
| PPE Net | 1,748 | 6,601 | 7,337 | N/A | N/A |
| Investments And Advances | 9,254 | 0 | 1,688 | 0 | 0 |
| Intangibles | 6,147 | 17,484 | 17,484 | 0 | 0 |
| Other Non-Current Assets | 7,118 | 8,249 | 8,221 | 301 | 25 |
| TOTAL | $24,267 | $32,334 | $34,731 | $301 | $25 |
| Total Assets | $35,370 | $51,833 | $67,627 | $70,687 | $65,929 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,389 | 3,422 | 5,635 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,989 | 1,677 | 3,102 | 1,769 | 1,769 |
| Accrued Expenses | 461 | 556 | 1,368 | 237 | 286 |
| Other current liabilities | 150 | 2,197 | 4,220 | N/A | N/A |
| TOTAL | $8,109 | $9,446 | $17,384 | $5,000 | $2,996 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,498 | 1,213 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 33 | N/A |
| Other Non-Current Liabilities | 1,126 | 1,724 | 21,096 | 12,763 | 12,763 |
| TOTAL | $1,108 | $4,528 | $22,917 | $12,763 | $12,763 |
| Total Liabilities | $9,216 | $13,975 | $40,301 | $17,763 | $15,758 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,334 | 1,009 | 857 | 1,397 | N/A |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -9,452 | -4,663 | -4,141 | 1,074 | N/A |
| Other shareholders' equity | -1,202 | 9,333 | -4 | 0 | -444 |
| TOTAL | $26,154 | $37,858 | $27,326 | $52,924 | $50,171 |
| Total Liabilities And Equity | $35,370 | $51,833 | $67,627 | $70,687 | $65,929 |